This morning we ran a column by Dr. Douglas Schoen, former adviser to President Clinton and founding partner of the polling firm Penn, Schoen, and Berland, on the results of some recent polling on Medicare Care Part D and the proposed government negotiation of drug prices. After a question was raised about the sponsorship of some of the polling cited we contacted Penn, Schoen, and Berland for a response. This is what we received:

The article that Doug wrote was based on 6 months of work that included some studies funded by the pharmaceutical industry and his comprehensive review of other publicly available data from Pew, Kaiser, Harris Interactive, and Dutko and other.

The attached documents speak to those studies which found similar results and led them to reach similar conclusions.

Doug wants to make clear that this article wholly represents his point of view and that he was told by no one what to say.

The attached documents cited in the email may be found here and here.